Human breast milk isolated lactic acid bacteria: antimicrobial and immunomodulatory activity on the Galleria mellonella burn wound model
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1428525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Antonio Guarnieri und 14 weiteren Autor:innen. Beteiligte Einrichtung: Università degli Studi del Molise Department of Medicina e Scienze della Salute "V. Tiberio", Campobasso, Italy. Hauptthemen laut MEDLINE: Burns, Pseudomonas aeruginosa, Disease Models, Animal, Lactobacillales. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Managing burn injuries is a challenge in healthcare. Due to the alarming increase in antibiotic resistance, new prophylactic and therapeutic strategies are being sought. This study aimed to evaluate the potential of live Lactic Acid Bacteria for managing burn infections, using Galleria mellonella larvae as an alternative preclinical animal model and comparing the outcomes with a common antibiotic.
Methods
The antimicrobial activity of LAB isolated from human breast milk was assessed in vitro against Pseudomonas aeruginosa ATCC 27853. Additionally, the immunomodulatory effects of LAB were evaluated in vivo using the G. mellonella burn wound infection model. Results and discussion In vitro results demonstrated the antimicrobial activity of Lactic Acid Bacteria against P. aeruginosa . In vivo results show that their prophylactic treatment improves, statistically significant, larval survival and modulates the expression of immunity-related genes, Gallerimycin and Relish/NF-κB, strain-dependently. These findings lay the foundation and suggest a promising alternative for burn wound prevention and management, reducing the risk of antibiotic resistance, enhancing immune modulation, and validating the potential G. mellonella as a skin burn wound model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Università degli Studi del Molise Department of Medicina e Scienze della Salute "V. Tiberio", Campobasso, Italy.
- Unità Operativa (UO) Laboratorio Analisi, Responsible Research Hospital, Campobasso, Italy.
- Università degli Studi del Molise Department of Agricultural, Environmental and Food Sciences, Campobasso, Italy.
- Università degli Studi di Catania Department of Drug and Health Sciences, Catania, Italy.
- ASReM-Azienda Sanitaria Regionale del Molise, Campobasso, Italy.
Zitieren
APA
Guarnieri, A., Venditti, N., Cutuli, M. A., Brancazio, N., Salvatore, G., Magnifico, I., Pietrangelo, L., Falcone, M., Vergalito, F., Nicolosi, D., Scarsella, F., Davinelli, S., Scapagnini, G., Petronio Petronio, G., & Di Marco, R. (2024). Human breast milk isolated lactic acid bacteria: antimicrobial and immunomodulatory activity on the Galleria mellonella burn wound model. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1428525
Vancouver
Guarnieri A, Venditti N, Cutuli MA, Brancazio N, Salvatore G, Magnifico I, et al. Human breast milk isolated lactic acid bacteria: antimicrobial and immunomodulatory activity on the Galleria mellonella burn wound model. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1428525
BibTeX
@article{Guarnieri2024,
author = {Guarnieri, Antonio and Venditti, Noemi and Cutuli, Marco Alfio and Brancazio, Natasha and Salvatore, Giovanna and Magnifico, Irene and Pietrangelo, Laura and Falcone, Marilina and Vergalito, Franca and Nicolosi, Daria and Scarsella, Franco and Davinelli, Sergio and Scapagnini, Giovanni and Petronio Petronio, Giulio and Di Marco, Roberto},
title = {Human breast milk isolated lactic acid bacteria: antimicrobial and immunomodulatory activity on the Galleria mellonella burn wound model},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1428525}
}
EUVIMED